These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 28754612)
21. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro. Nikolova T; Wu M; Brumbarov K; Alt R; Opitz H; Boheler KR; Cross M; Wobus AM Differentiation; 2007 Feb; 75(2):100-11. PubMed ID: 17316380 [TBL] [Abstract][Full Text] [Related]
22. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells. Panepucci RA; Oliveira LH; Zanette DL; Viu Carrara Rde C; Araujo AG; Orellana MD; Bonini de Palma PV; Menezes CC; Covas DT; Zago MA Stem Cells Dev; 2010 Mar; 19(3):321-32. PubMed ID: 19686049 [TBL] [Abstract][Full Text] [Related]
23. MicroRNAs as markers for neurally committed CD133+/CD34+ stem cells derived from human umbilical cord blood. Hafizi M; Atashi A; Bakhshandeh B; Kabiri M; Nadri S; Hosseini RH; Soleimani M Biochem Genet; 2013 Apr; 51(3-4):175-88. PubMed ID: 23135476 [TBL] [Abstract][Full Text] [Related]
24. Expression of CXCR4 in cord blood-derived CD133+ cells treated with platelet micro-particles. Moghaddam F; Oodi A; Nikougoftar Zarif M; Amani M; Amirizadeh N Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1702-7. PubMed ID: 26466742 [TBL] [Abstract][Full Text] [Related]
25. GMP-conformant on-site manufacturing of a CD133 Skorska A; Müller P; Gaebel R; Große J; Lemcke H; Lux CA; Bastian M; Hausburg F; Zarniko N; Bubritzki S; Ruch U; Tiedemann G; David R; Steinhoff G Stem Cell Res Ther; 2017 Feb; 8(1):33. PubMed ID: 28187777 [TBL] [Abstract][Full Text] [Related]
26. Platelet growth factors suppress ex vivo expansion and enhance differentiation of umbilical cord blood CD133+ stem cells to megakaryocyte progenitor cells. Aghideh AN; Kheirandish M; Abolghasemi H; Gharehbaghian A Growth Factors; 2010 Dec; 28(6):409-16. PubMed ID: 20854188 [TBL] [Abstract][Full Text] [Related]
27. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells. Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761 [TBL] [Abstract][Full Text] [Related]
29. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture]. Hao SG; Sun GL; Wu WL; Wu YL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136 [TBL] [Abstract][Full Text] [Related]
30. Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model. Sasaki H; Ishikawa M; Tanaka N; Nakanishi K; Kamei N; Asahara T; Ochi M Spine (Phila Pa 1976); 2009 Feb; 34(3):249-54. PubMed ID: 19148043 [TBL] [Abstract][Full Text] [Related]
31. Differentiation of neural crest stem cells from nasal mucosa into motor neuron-like cells. Bagher Z; Kamrava SK; Alizadeh R; Farhadi M; Absalan M; Falah M; Faghihi F; Zare-Sadeghi A; Komeili A J Chem Neuroanat; 2018 Oct; 92():35-40. PubMed ID: 29807106 [TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Tondreau T; Meuleman N; Delforge A; Dejeneffe M; Leroy R; Massy M; Mortier C; Bron D; Lagneaux L Stem Cells; 2005 Sep; 23(8):1105-12. PubMed ID: 15955825 [TBL] [Abstract][Full Text] [Related]
33. Intermediate filament nestin expressions in human cord blood monocytes (HCMNCs). Ha Y; Lee JE; Kim KN; Cho YE; Yoon DH Acta Neurochir (Wien); 2003 Jun; 145(6):483-7. PubMed ID: 12836073 [TBL] [Abstract][Full Text] [Related]
34. Induction of mice adult bone marrow mesenchymal stem cells into functional motor neuron-like cells. Abdullah RH; Yaseen NY; Salih SM; Al-Juboory AA; Hassan A; Al-Shammari AM J Chem Neuroanat; 2016 Nov; 77():129-142. PubMed ID: 27417692 [TBL] [Abstract][Full Text] [Related]
36. The frequency of multipotent CD133(+)CD45RA(-)CD34(+) hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources. Radtke S; Haworth KG; Kiem HP Exp Hematol; 2016 Jun; 44(6):502-7. PubMed ID: 27016273 [TBL] [Abstract][Full Text] [Related]
37. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674 [TBL] [Abstract][Full Text] [Related]
38. Umbilical cord blood stem cells: induction of differentiation into mesenchymal lineages by cell-cell contacts with various mesenchymal cells. Park J; Setter V; Wixler V; Schneider H Tissue Eng Part A; 2009 Feb; 15(2):397-406. PubMed ID: 18759667 [TBL] [Abstract][Full Text] [Related]
39. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia. Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851 [TBL] [Abstract][Full Text] [Related]
40. Isolation of three important types of stem cells from the same samples of banked umbilical cord blood. Phuc PV; Ngoc VB; Lam DH; Tam NT; Viet PQ; Ngoc PK Cell Tissue Bank; 2012 Jun; 13(2):341-51. PubMed ID: 21656022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]